166 related articles for article (PubMed ID: 28539276)
1. [Expectant therapy versus curettage for retained products of conception after second trimester termination of pregnancy: analysis of outcomes and complications].
Zeng WJ; An SL; Huang H; Huang QT; Li FF; Wang HZ; Cai DC; Gao YF
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):569-574. PubMed ID: 28539276
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Reproductive Outcomes following Retained Products of Conception after Vaginal Delivery versus First-Trimester Abortion.
Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R; Ben-Ami I
Gynecol Obstet Invest; 2015; 80(3):206-10. PubMed ID: 26088169
[TBL] [Abstract][Full Text] [Related]
3. Expectant management of retained products of conception following abortion: A retrospective cohort study.
Wada Y; Takahashi H; Suzuki H; Ohashi M; Ogoyama M; Nagayama S; Baba Y; Usui R; Suzuki T; Ohkuchi A; Fujiwara H
Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():1-5. PubMed ID: 33689917
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and therapeutic decision-making with transvaginal sonography for first trimester spontaneous abortion, clinically thought to be incomplete or complete.
Cetin A; Cetin M
Contraception; 1998 Jun; 57(6):393-7. PubMed ID: 9693399
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of retained products of conception after miscarriage or termination with gemeprost in the second trimester of pregnancy: a retrospective case-controlled study in Japanese population.
Noguchi T; Shiro M; Nanjo S; Mizoguchi M; Ota N; Mabuchi Y; Yagi S; Minami S; Ino K
J Obstet Gynaecol; 2022 Apr; 42(3):501-504. PubMed ID: 34162287
[TBL] [Abstract][Full Text] [Related]
6. Expectant, medical, or surgical treatment of spontaneous abortion in first trimester of pregnancy? A pooled quantitative literature evaluation.
Geyman JP; Oliver LM; Sullivan SD
J Am Board Fam Pract; 1999; 12(1):55-64. PubMed ID: 10050644
[TBL] [Abstract][Full Text] [Related]
7. Curettage after midtrimester termination of pregnancy. Is it necessary?
Lurie S; Appelman Z; Katz Z
J Reprod Med; 1991 Nov; 36(11):786-8. PubMed ID: 1765956
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonographic vascularity assessment for predicting future severe hemorrhage in retained products of conception after second-trimester abortion.
Akiba N; Iriyama T; Nakayama T; Seyama T; Sayama S; Kumasawa K; Komatsu A; Yabe S; Nagamatsu T; Osuga Y; Fujii T
J Matern Fetal Neonatal Med; 2021 Feb; 34(4):562-568. PubMed ID: 31006292
[No Abstract] [Full Text] [Related]
9. Expectant management of first-trimester spontaneous abortion.
Nielsen S; Hahlin M
Lancet; 1995 Jan; 345(8942):84-6. PubMed ID: 7815886
[TBL] [Abstract][Full Text] [Related]
10. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
[TBL] [Abstract][Full Text] [Related]
11. Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting.
Cates W; Schulz KF; Grimes DA; Horowitz AJ; Lyon FA; Kravitz FH; Frisch MJ
JAMA; 1982 Aug; 248(5):559-63. PubMed ID: 6285012
[TBL] [Abstract][Full Text] [Related]
12. Expectant versus surgical management of first-trimester miscarriage: a randomised controlled study.
Al-Ma'ani W; Solomayer EF; Hammadeh M
Arch Gynecol Obstet; 2014 May; 289(5):1011-5. PubMed ID: 24240972
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
Hershko Klement A; Frederic M; Bentov Y; Chang P; Nayot D; Haas J; Casper RF
Gynecol Endocrinol; 2018 Jul; 34(7):609-611. PubMed ID: 29345165
[TBL] [Abstract][Full Text] [Related]
14. Early complications after induced first-trimester abortion.
Heisterberg L; Kringelbach M
Acta Obstet Gynecol Scand; 1987; 66(3):201-4. PubMed ID: 3661126
[TBL] [Abstract][Full Text] [Related]
15. Uterine curettage following second trimester abortion by extraovular instillation of prostaglandin E2. A prospective-randomized trial.
Atad J; Hallak M; Fruchter O; Yshai D; Auslender R; Abramovici H
Eur J Obstet Gynecol Reprod Biol; 1999 Aug; 85(2):147-50. PubMed ID: 10584627
[TBL] [Abstract][Full Text] [Related]
16. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report.
Alonso L; Nieto L; Carugno J
J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
Liang H; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
Contraception; 2011 Dec; 84(6):609-14. PubMed ID: 22078190
[TBL] [Abstract][Full Text] [Related]
18. Role of transvaginal sonography in the diagnosis of retained products of conception.
Ustunyurt E; Kaymak O; Iskender C; Ustunyurt OB; Celik C; Danisman N
Arch Gynecol Obstet; 2008 Feb; 277(2):151-4. PubMed ID: 17710427
[TBL] [Abstract][Full Text] [Related]
19. Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage.
Ngai SW; Chan YM; Tang OS; Ho PC
Hum Reprod; 2001 Jul; 16(7):1493-6. PubMed ID: 11425836
[TBL] [Abstract][Full Text] [Related]
20. Expectant management versus elective curettage for the treatment of spontaneous abortion.
Hurd WW; Whitfield RR; Randolph JF; Kercher ML
Fertil Steril; 1997 Oct; 68(4):601-6. PubMed ID: 9341597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
